StockScan > Holders > Bronte Capital Management Pty

Bronte Capital Management Pty's Portfolio and 13F Filing

Value: $578M
CIK: 0001471085
Phone: 0417337961
Address: Suite 1703, 101 Grafton St, Bondi Junction, C3 (2022)
Latest 13F Filing: 2026-08-05
Bronte Capital Management Pty's Stock Holdings & 13F Form
# Stock Name Symbol Current Price

Previous Holdings

(# Shares)

Current Holdings

(# Shares)

Current Value Percent
21 Herbalife Ltd. HLF $14.19 N/A 323,386 $4,588,847 0.79%
22 Revolution Medicines, Inc. Common Stock RVMD $193.52 N/A 18,780 $3,634,306 0.63%
23 Mondelez International, Inc. Class A MDLZ $62.57 N/A 53,234 $3,330,851 0.58%
24 iShares Core S&P Small-Cap ETF IJR $135.41 N/A 23,004 $3,114,972 0.54%
25 Tyler Technologies, Inc. TYL $350.11 N/A 8,302 $2,906,613 0.50%
26 Paylocity Holding Corporation Common Stock PCTY $159.10 N/A 17,874 $2,843,753 0.49%
27 Brown-Forman Corporation Class A BF.A $28.85 N/A 95,365 $2,751,280 0.48%
28 Bath & Body Works, Inc. BBWI $18.95 N/A 143,800 $2,725,010 0.47%
29 Turning Point Brands, Inc. TPB $57.70 N/A 40,721 $2,349,602 0.41%
30 NICE Ltd NICE $111.00 N/A 16,396 $1,819,956 0.31%
31 Universal Display Corp OLED $74.95 N/A 10,269 $769,662 0.13%
32 Gossamer Bio, Inc. Common Stock GOSS $8.91 N/A 67,754 $603,349 0.10%
33 Verisk Analytics, Inc. Common Stock VRSK $180.58 N/A 2,682 $484,316 0.08%
34 Enovix Corporation Common Stock ENVX $2.44 N/A 41,765 $101,907 0.02%
35 Treace Medical Concepts, Inc. Common Stock TMCI $4.04 N/A 15,577 $62,931 0.01%
36 Fate Therapeutics, Inc. FATE $1.94 N/A 21,740 $42,176 0.01%
37 PepGen Inc. Common Stock PEPG $2.32 N/A 17,776 $41,240 0.01%
38 AN2 Therapeutics, Inc. Common Stock ANTX $3.54 N/A 10,895 $38,568 0.01%
39 Pacific Biosciences of California, Inc. PACB $1.99 N/A 17,881 $35,583 0.01%
40 Commerce.com, Inc. Series 1 Common Stock CMRC $3.28 N/A 10,278 $33,712 0.01%